• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗1周后,高剂量异烟肼用于治疗对异烟肼低至中度耐药的结核病。

High-dose isoniazid for TB with low-to-moderate isoniazid resistance after 1 week of treatment.

作者信息

Ranganathan U D, Smith-Jeffcoat S E, Balaji S, Devika K, Nair D, Devaleenal Daniel B, Srinivasan R, Baskaran M, RaviKumar D, Sangamithirai D, Radhika G, Mangalambal G, Lavanya J, Maheswaran K, Kumar S, Sridhar R, Tripathy S, Swaminathan S, Eisenach K D, Cegielski J P

机构信息

Departments of Microbiology, Immunology and Clinical Research, Indian Council for Medical Research-National Institute of Research for Tuberculosis, Chennai, India.

Division of Global HIV and TB, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.

出版信息

JAC Antimicrob Resist. 2025 May 22;7(3):dlaf072. doi: 10.1093/jacamr/dlaf072. eCollection 2025 Jun.

DOI:10.1093/jacamr/dlaf072
PMID:40406736
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12096161/
Abstract

OBJECTIVES

To evaluate the effect of high-dose isoniazid in patients with isoniazid-resistant TB by its bactericidal activity after 1 or more weeks of treatment.

SUBJECTS AND METHODS

Using the rapid direct method of phenotypic drug susceptibility testing, we screened persons with positive sputum microscopy results and genotypic drug resistance for isoniazid resistance. Those with no growth at a critical concentration of 2.0 mg/L were invited to participate in a trial of high-dose isoniazid monotherapy lasting 6 days. After 3 days of no treatment, patients received isoniazid 15 mg/kg and were followed with serial quantitative sputum cultures from Days 0 to 6.

RESULTS

We enrolled 15 patients after a median of 2 weeks standard first-line treatment. Their median bacillary count on Day 0 was 4.9 log cfu/mL on solid agar, and the time to detection (TTD) was 200 h in liquid medium. Neither metric showed meaningful change in bacillary burden over 6 days, declining by a non-significant 0.08 log cfu/mL/d on solid media and slowing TTD by 23 h. These effects did not differ by degree of isoniazid resistance or specific ( gene mutations.

CONCLUSIONS

The utility of high-dose isoniazid against low-level isoniazid resistance beyond the first 2 weeks of chemotherapy should be reconsidered.

摘要

目的

通过治疗1周或更长时间后的杀菌活性,评估大剂量异烟肼对耐异烟肼结核病患者的疗效。

对象与方法

采用快速直接表型药敏试验方法,我们对痰涂片镜检结果阳性且对异烟肼具有基因型耐药性的患者进行筛查,以确定其对异烟肼的耐药情况。那些在2.0mg/L临界浓度下无生长的患者被邀请参加为期6天的大剂量异烟肼单药治疗试验。在3天未治疗后,患者接受15mg/kg异烟肼治疗,并在第0天至第6天进行系列定量痰培养随访。

结果

在经过中位时间为2周的标准一线治疗后,我们纳入了15名患者。他们在第0天在固体琼脂上的中位菌量为4.9 log cfu/mL,在液体培养基中的检测时间(TTD)为200小时。在6天内,这两个指标均未显示出细菌负荷的有意义变化,在固体培养基上细菌负荷以无统计学意义的0.08 log cfu/mL/天下降,TTD减慢23小时。这些效应在异烟肼耐药程度或特定基因突变方面无差异。

结论

应重新考虑大剂量异烟肼在化疗2周后对低水平异烟肼耐药的作用。

相似文献

1
High-dose isoniazid for TB with low-to-moderate isoniazid resistance after 1 week of treatment.治疗1周后,高剂量异烟肼用于治疗对异烟肼低至中度耐药的结核病。
JAC Antimicrob Resist. 2025 May 22;7(3):dlaf072. doi: 10.1093/jacamr/dlaf072. eCollection 2025 Jun.
2
Early Bactericidal Activity of Different Isoniazid Doses for Drug-Resistant Tuberculosis (INHindsight): A Randomized, Open-Label Clinical Trial.不同异烟肼剂量对耐多药结核病的早期杀菌活性(事后回顾):一项随机、开放标签的临床试验
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1416-1424. doi: 10.1164/rccm.201910-1960OC.
3
Erratum: High-Throughput Identification of Resistance to Pseudomonas syringae pv. Tomato in Tomato using Seedling Flood Assay.勘误:利用幼苗浸没法高通量鉴定番茄对丁香假单胞菌 pv.番茄的抗性。
J Vis Exp. 2023 Oct 18(200). doi: 10.3791/6576.
4
A Semimechanistic Model of the Bactericidal Activity of High-Dose Isoniazid against Multidrug-Resistant Tuberculosis: Results from a Randomized Clinical Trial.高剂量异烟肼对耐多药结核病杀菌活性的半机制模型:一项随机临床试验的结果
Am J Respir Crit Care Med. 2021 Dec 1;204(11):1327-1335. doi: 10.1164/rccm.202103-0534OC.
5
High-Dose Isoniazid Lacks EARLY Bactericidal Activity against Isoniazid-resistant Tuberculosis Mediated by katG Mutations: A Randomized Phase II Clinical Trial.高剂量异烟肼缺乏对 katG 突变介导的耐异烟肼结核病的早期杀菌活性:一项随机、Ⅱ期临床试验。
Am J Respir Crit Care Med. 2024 Aug 1;210(3):343-351. doi: 10.1164/rccm.202311-2004OC.
6
Safety, bactericidal activity, and pharmacokinetics of the antituberculosis drug candidate BTZ-043 in South Africa (PanACEA-BTZ-043-02): an open-label, dose-expansion, randomised, controlled, phase 1b/2a trial.抗结核候选药物BTZ-043在南非的安全性、杀菌活性和药代动力学研究(泛亚ACEA-BTZ-043-02):一项开放标签、剂量扩展、随机、对照的1b/2a期试验。
Lancet Microbe. 2025 Feb;6(2):100952. doi: 10.1016/j.lanmic.2024.07.015. Epub 2025 Jan 7.
7
High Prevalence of inhA Promoter Mutations among Patients with Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa.南非夸祖鲁-纳塔尔省耐多药结核病患者中inhA启动子突变的高流行率
PLoS One. 2015 Sep 2;10(9):e0135003. doi: 10.1371/journal.pone.0135003. eCollection 2015.
8
Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin.Xpert MTB/XDR 检测系统用于检测肺结核病及异烟肼、氟喹诺酮类、乙胺丁醇和阿米卡星耐药性。
Cochrane Database Syst Rev. 2022 May 18;5(5):CD014841. doi: 10.1002/14651858.CD014841.pub2.
9
Time to detection of the growth of Mycobacterium tuberculosis in MGIT 960 for determining the early bactericidal activity of antituberculosis agents.MGIT 960 中检测结核分枝杆菌生长以确定抗结核药物早期杀菌活性所需的时间。
Eur J Clin Microbiol Infect Dis. 2010 Dec;29(12):1561-5. doi: 10.1007/s10096-010-1043-7. Epub 2010 Sep 4.
10
The management of tuberculosis: epidemiology, resistance and monitoring.结核病的管理:流行病学、耐药性与监测
Dan Med Bull. 2010 Nov;57(11):B4213.

本文引用的文献

1
Identifying isoniazid resistance markers to guide inclusion of high-dose isoniazid in tuberculosis treatment regimens.鉴定异烟肼耐药标志物,以指导将高剂量异烟肼纳入结核病治疗方案。
Clin Microbiol Infect. 2020 Oct;26(10):1332-1337. doi: 10.1016/j.cmi.2020.07.004. Epub 2020 Jul 9.
2
Early Bactericidal Activity of Different Isoniazid Doses for Drug-Resistant Tuberculosis (INHindsight): A Randomized, Open-Label Clinical Trial.不同异烟肼剂量对耐多药结核病的早期杀菌活性(事后回顾):一项随机、开放标签的临床试验
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1416-1424. doi: 10.1164/rccm.201910-1960OC.
3
Isoniazid resistance levels of Mycobacterium tuberculosis can largely be predicted by high-confidence resistance-conferring mutations.结核分枝杆菌的异烟肼耐药水平很大程度上可以通过高可信度耐药相关突变来预测。
Sci Rep. 2018 Feb 19;8(1):3246. doi: 10.1038/s41598-018-21378-x.
4
Comparing the Efficacy of Drug Regimens for Pulmonary Tuberculosis: Meta-analysis of Endpoints in Early-Phase Clinical Trials.比较肺结核药物治疗方案的疗效:早期临床试验终点的荟萃分析。
Clin Infect Dis. 2017 Jul 1;65(1):46-54. doi: 10.1093/cid/cix247.
5
Concentration-Dependent Antagonism and Culture Conversion in Pulmonary Tuberculosis.肺结核中的浓度依赖性拮抗作用与培养转化
Clin Infect Dis. 2017 May 15;64(10):1350-1359. doi: 10.1093/cid/cix158.
6
Rationale for high-dose isoniazid in the treatment of multidrug-resistant tuberculosis.大剂量异烟肼治疗耐多药结核病的理论依据。
Int J Tuberc Lung Dis. 2017 Jan 1;21(1):123-124. doi: 10.5588/ijtld.16.0619.
7
Time Trends in Sputum Mycobacterial Load and Two-Day Bactericidal Activity of Isoniazid-Containing Antituberculosis Therapies.含异烟肼抗结核治疗的痰液分枝杆菌载量及两日杀菌活性的时间趋势
Antimicrob Agents Chemother. 2017 Mar 24;61(4). doi: 10.1128/AAC.02088-16. Print 2017 Apr.
8
Pre-treatment mycobacterial sputum load influences individual on-treatment measurements.治疗前的分枝杆菌痰菌载量会影响个体的治疗期间测量结果。
Tuberculosis (Edinb). 2014 Dec;94(6):690-4. doi: 10.1016/j.tube.2014.08.015.
9
The early bactericidal activity of antituberculosis drugs.抗结核药物的早期杀菌活性。
Expert Rev Anti Infect Ther. 2014 Feb;12(2):223-37. doi: 10.1586/14787210.2014.870884. Epub 2014 Jan 6.
10
Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study.耐多药结核病患者二线药物耐药的流行情况及危险因素:一项前瞻性队列研究。
Lancet. 2012 Oct 20;380(9851):1406-17. doi: 10.1016/S0140-6736(12)60734-X. Epub 2012 Aug 30.